Alector is now focusing on its remaining pipeline, including nivisnebart (AL101/GSK4527226), which is being evaluated in a Phase 2 trial for early Alzheimer’s disease with completion expected in 2026.

Alector (ALEC) recently reported that its experimental therapy latozinemab did not meet the main efficacy goal in a late-stage trial for frontotemporal dementia. As a result, multiple follow-up ...

Make no mistake: Frederique Constant is a luxury watch brand. Although priced below its competition, FC produces solid gold watches and makes its own tourbillon, flyback chronograph, and even ...

The Herald Sun can reveal Mr Mirabella, who was listed as a defendant in the Supreme Court case challenging the validity of a $1.55m rescue loan issued to Hawthorn MP John Pesutto, has switched sides ...

Halloween is here, and households across the nation are preparing for an evening of visitors, ringing doorbells and characters wandering the streets. But experts have issued a warning to Irish ...

It was once more a day dominated by diplomacy as Donald Trump's team looked to shore up the US-brokered ceasefire agreement that came under strain over the weekend. Israel was meanwhile served with a ...

When the next UK heatwave hits, a portable air conditioner can feel like an absolute lifesaver, especially if your home tends to trap heat upstairs, when you're trying to sleep or work. However, the ...